-+ 0.00%
-+ 0.00%
-+ 0.00%

Cipher Pharmaceuticals Q3 2026 Net Income Jumps 98% Year Over Year to USD 10.9 Million

PUBT·11/12/2026 22:16:25
Listen to the news
Cipher Pharmaceuticals Q3 2026 Net Income Jumps 98% Year Over Year to USD 10.9 Million
  • Cipher Pharmaceuticals’ Q3 2026 net income jumped 98% year-over-year to USD 10.9 million, including USD 4.9 million in arbitration-related benefits.
  • Net revenue fell year-over-year to USD 12.7 million.
  • Operating cash flows dropped 21% year-over-year to USD 8.5 million, while quarter-end cash stood at USD 15.3 million.
  • Expanded public reimbursement for Epuris took effect in British Columbia, Québec and Alberta.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cipher Pharmaceuticals Inc. published the original content used to generate this news brief via CNW (Ref. ID: 202611121700CANADANWCANADAPR_C4681) on November 12, 2026, and is solely responsible for the information contained therein.